China’s healthcare fund watchdog is taking AstraZeneca to task over alleged fraud. AstraZeneca China last month met with government officials as part of an investigation into alleged insurance fraud, the company said Friday. The probe and subsequent arrests hinge on suspicions that AZ China staff members tampered with genetic testing results of cancer patients in order to defraud medical insurance funds.